Momenta Pharmaceuticals Inc (MNTA)
Email Confirmation
OPEN
LAST
$
PREV CLOSE
CHANGE
VOLUME
Overview
News
People
Financials
Company Information
Overview
A biotechnology company, specializing in the structural analysis of complex mixture drugs, applying its technology to the development of generic or follow-on versions of complex drug products as well as to the discovery and development of novel drugs.
Press Releases
-
BeaconEquity.com Issues TraderNotes on Active Stocks: SPSN, CHCG, DTPI, AMKR, TQNT, MNTA, CBPC, ABAT Jul-14-2008, 10:00AM EDT
News From Around the Web
News
-
Momenta Pharmaceuticals Appoints Bruce A. Leicher as General Counsel
(PrimeZone Media Network)Jul 24 2008
Employees
Number of Employees: 163
Revenue per Employee: $101,954
Top Executives
Dr. John E. Bishop, Ph.D., Divisional Senior VP
Steven B. Brugger, COO
Richard P. Shea, CFO/Senior VP
Dr. Ganesh Venkataraman, Ph.D., Divisional Senior VP/Founder/Chief Scientific Officer
Dr. James M. Roach, M.D, Senior VP, Divisional/Chief Medical Officer
Lisa Carron Shmerling, Esq., Divisional Vice President/Secretary
Board of Directors
Peter Barton Hutt, Director
Dr. Ram Sasisekharan, Ph.D., Founder/Director
Dr. Peter Barrett, Ph.D., Chairman of the Board/Director
Alan L. Crane, Director
Dr. Elizabeth Stoner, M.D., Director
Dr.Robert S. Langer, Sc.D., Director/Founder
Financials
Quarterly
Annual
| Income Statement | 05/2008 | 02/2008 | 11/2007 | 08/2007 |
|---|---|---|---|---|
| Sales | NA | NA | -4.37 Mil. | 809 K. |
| Gross Operating Profit | 4.15 Mil. | 10 Mil. | 9.52 Mil. | 3.37 Mil. |
| Operating Income before D & A (EBITDA) | -14.54 Mil. | -15.85 Mil. | -16.28 Mil. | -21.63 Mil. |
| Total Income Before Interest Expenses (EBIT) | -13.34 Mil. | -14.29 Mil. | -18.65 Mil. | -18.58 Mil. |
| Total Net Income | -13.34 Mil. | -14.29 Mil. | -18.87 Mil. | -18.76 Mil. |
| Basic EPS, Total | -0.37 | -0.4 | -0.53 | -0.53 |
| Diluted EPS, Total | -0.37 | -0.4 | -0.53 | -0.53 |
| BALANCE STATEMENT | 05/2008 | 02/2008 | 11/2007 | 08/2007 |
|---|---|---|---|---|
| Cash and Equivalents | 123.56 Mil. | 135.94 Mil. | 18.31 Mil. | 15.96 Mil. |
| Total Assets | NA | NA | 149.87 Mil. | 167.27 Mil. |
| Total Liabilities | 14.93 Mil. | 22.41 Mil. | 19.23 Mil. | 18.4 Mil. |
| Total Capitalization | 116.54 Mil. | 127.54 Mil. | 138.74 Mil. | 154.61 Mil. |
| Cash Flow | 05/2008 | 02/2008 | 11/2007 | 08/2007 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | NA | -47.25 Mil. | -28.38 Mil. |
| Net Cash From Investing Activities | NA | NA | 40.37 Mil. | 20.4 Mil. |
| Net Cash From Financing Activities | NA | NA | 2.84 Mil. | 1.6 Mil. |
| Net Change in Cash & Cash Equivalents | NA | NA | -4.04 Mil. | -6.39 Mil. |
| Income Statement | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Sales | NA | -245 K. | -2.02 Mil. | -1.54 Mil. |
| Gross Operating Profit | 21.56 Mil. | 16.24 Mil. | 16.5 Mil. | 9.37 Mil. |
| Operating Income before D & A (EBITDA) | -76.56 Mil. | -59.14 Mil. | -22.74 Mil. | -13.1 Mil. |
| Total Income Before Interest Expenses (EBIT) | -68.88 Mil. | -51.41 Mil. | -21.4 Mil. | -14.04 Mil. |
| Total Net Income | -68.88 Mil. | -51.91 Mil. | -21.66 Mil. | -14.08 Mil. |
| Basic EPS, Total | -1.93 | -1.62 | -0.79 | -2.56 |
| Diluted EPS, Total | -1.93 | -1.62 | -0.79 | -2.56 |
| BALANCE STATEMENT | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Cash and Equivalents | 135.94 Mil. | 22.35 Mil. | 25.89 Mil. | 11.68 Mil. |
| Total Assets | NA | 198.06 Mil. | 163.4 Mil. | 60.12 Mil. |
| Total Liabilities | 22.41 Mil. | 12.76 Mil. | 7.74 Mil. | 5.96 Mil. |
| Total Capitalization | 127.54 Mil. | 183.33 Mil. | 163.15 Mil. | 58.1 Mil. |
| Cash Flow | 2008 | 2007 | 2006 | 2005 |
|---|---|---|---|---|
| Net Cash From Continuing Operations | NA | -25.21 Mil. | -17.02 Mil. | -12.55 Mil. |
| Net Cash From Investing Activities | NA | -46.34 Mil. | -93.28 Mil. | -37.25 Mil. |
| Net Cash From Financing Activities | NA | 68.02 Mil. | 124.51 Mil. | 56.86 Mil. |
| Net Change in Cash & Cash Equivalents | NA | -3.54 Mil. | 14.21 Mil. | 7.06 Mil. |
Related Companies by Market Cap
Company Name
Price
Change
Market Cap
216.8 Mil.
215.89 Mil.
227.06 Mil.
212.12 Mil.
Company Profile Change Request
The data provided in our company profiles comes from third party information providers.- If you have a change request regarding a publicly traded company, click here
- If your request pertains to a private company, click here
Also in Portfolio.com
Most Emailed
Recently Commented
TOP 5
(Daily)
A smart take on the top stories shaping the business world.
Executives & Careers
(Tuesdays)
A weekly guide to the personalities and ideas that are transforming the business world.
Inside Portfolio.com
(Wednesdays)
Our roundup of the week's best from Portfolio.com.
Culture & Lifestyle
(Fridays)
A weekly guide to the best ways to spend your time - and money.
In This Issue
(Monthly)
Be the first to know when the latest issue of Condé Nast Portfolio magazine is online.


